MiR-34a reverses radiation resistance on ECA-109 cells by inhibiting PI3K/AKT/mTOR signal pathway through downregulating the expression of SIRT1

References

• Cao B, Shi Q, Wang W. 2015. Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin. J Thorac Dis. 7(4):711–719.
   PubMed Web of Science ®Google Scholar
• Dai S, Ye Z, Wang F, Yan F, Wang L, Fang J, Wang Z, Fu Z. 2018. Doxorubicin-loaded poly(ε-caprolactone)-Pluronic micelle for targeted therapy of esophageal cancer. J Cell Biochem. 119(11):9017–9027.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, van Baardwijk A, Steevens J, Botterweck A, Bosmans G, Reymen B, Wanders R, Borger J, Dingemans AM, Bootsma G, et al. 2012. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study. Radiotherapy and Oncology: journal of the European Society for Therapeutic Radiology and Oncology. 102(2):228–233.
   PubMed Web of Science ®Google Scholar
• Dorn GW. 2nd. 2013. miR-34a and the cardiomyopathy of senescence: SALT PNUTS, SALT PNUTS!. Cell Metab. 17(5):629–630.
   PubMed Web of Science ®Google Scholar
• Fan YN, Meley D, Pizer B, See V. 2014. Mir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cells. PloS One. 9(9):e108514.
   PubMed Web of Science ®Google Scholar
• Huang Y, Yu J, Wan F, Zhang W, Yang H, Wang L, Qi H, Wu C. 2014. Panaxatriol saponins attenuated oxygen-glucose deprivation injury in PC12 cells via activation of PI3K/Akt and Nrf2 signaling pathway. Oxid Med Cell Longev. 2014:978034.
   PubMed Web of Science ®Google Scholar
• Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, Riera TV, Lee JE, E SY, Lamming DW, et al. 2013. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 339(6124):1216–1219.
   PubMed Web of Science ®Google Scholar
• Imanishi T, Hano T, Matsuo Y, Nishio I. 2003. Oxidized low-density lipoprotein inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol. 30(9):665–670.
   PubMed Web of Science ®Google Scholar
• Jamal M, Rath BH, Williams ES, Camphausen K, Tofilon PJ. 2010. Microenvironmental regulation of glioblastoma radioresponse. Clin Cancer Res. 16(24):6049–6059.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J Clin. 60(5):277–300.
   PubMed Web of Science ®Google Scholar
• Joubert A, Vogin G, Devic C, Granzotto A, Viau M, Maalouf M, Thomas C, Colin C, Foray N. 2011. [Radiation biology: major advances and perspectives for radiotherapy]. Cancer Radiother. 15(5):348–354.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Tannock IF. 2005. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 5(7):516–525.
   PubMed Web of Science ®Google Scholar
• Ming GF, Tang YJ, Hu K, Chen Y, Huang WH, Xiao J. 2016. Visfatin attenuates the ox-LDL-induced senescence of endothelial progenitor cells by upregulating SIRT1 expression through the PI3K/Akt/ERK pathway. Int J Mol Med. 38(2):643–649.
   PubMed Web of Science ®Google Scholar
• Shi H, Zhou S, Liu J, Zhu J, Xue J, Gu L, Chen Y. 2016. miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer. Pathol Res Pract. 212(5):444–449.
   PubMed Web of Science ®Google Scholar
• Shibata-Kobayashi S, Yamashita H, Okuma K, Shiraishi K, Igaki H, Ohtomo K, Nakagawa K. 2013. Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-alpha, NF-kappaB, TGF-beta, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1alpha] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma. Oncology Letters. 5(3):903–910.
   PubMed Web of Science ®Google Scholar
• Wang X, Dong K, Gao P, Long M, Lin F, Weng Y, Ouyang Y, Ren J, Zhang H. 2013. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status. Cancer Biother Radiopharm. 28(1):45–50.
   PubMed Web of Science ®Google Scholar
• Whibley C, Pharoah PD, Hollstein M. 2009. p53 polymorphisms: cancer implications. Nat Rev Cancer. 9(2):95–107.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Li CH, Chan SL, Xu F, Feng L, Wang Y, Jiang JD, Sung JJ, Cheng CH, Chen Y. 2014. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma. Cancer Res. 74(21):6236–6247.
   PubMed Web of Science ®Google Scholar
• Ye Z, Fang J, Dai S, Wang Y, Fu Z, Feng W, Wei Q, Huang P. 2016. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background. Cancer Lett. 370(2):216–221.
   PubMed Web of Science ®Google Scholar
• Ye Z, Fang J, Dai S, Xie T, Wang F, Wang Z, Li K, Fu Z, Wang Y. 2017. Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors. Oncotarget. 8(54):92880–92889.
   PubMedGoogle Scholar
• Ye ZM, Dai SJ, Yan FQ, Wang L, Fang J, Fu ZF, Wang YZ. 2018. DCE-MRI-Derived Volume Transfer Constant (Ktrans) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal Cancer. Technol Cancer Res Treat. 17:1533034618765254.
   Web of Science ®Google Scholar
• Zhao Y, Yi J, Tao L, Huang G, Chu X, Song H, Chen L. 2018. Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma. Cell Death Dis. 9(4):433.
   PubMed Web of Science ®Google Scholar